About EchoVice
EchoVice is a Danish medtech company developing practical medical device solutions for cardiac care. We combine engineering expertise, clinical insight, and user-centered design to create technology that supports clinicians in real-world healthcare environments.
Our Mission
Our mission is to make advanced cardiac care easier to perform by creating tools that support clinicians at critical moments.
We focus on reducing unnecessary complexity in the clinical workflow, so healthcare professionals can spend less time managing equipment and more time focusing on patients, imaging, and decision-making.
We focus on reducing unnecessary complexity in the clinical workflow, so healthcare professionals can spend less time managing equipment and more time focusing on patients, imaging, and decision-making.
Clinical Relevance
Every solution starts with a real clinical challenge. We work to understand how cardiac care is performed in practice before developing tools around those needs.
Engineering Expertise
We turn clinical insight into practical medical device solutions through structured development, prototyping, testing, and refinement.
User-Centered Design
We involve clinicians throughout the process to create solutions that are intuitive, reliable, and easy to integrate into existing workflows.
Our Mission
Clinical Excellence
Every product idea is shaped around real needs from cardiac care environments, where precision, reliability, and usability are essential.
Precision Engineering
We combine engineering expertise with practical testing to create medical device solutions that are stable, intuitive, and built for demanding clinical workflows.
Workflow Integration
Our solutions are designed to fit naturally into existing procedures, helping clinicians work more efficiently without adding unnecessary steps or complexity.
Our History
EchoVice began as a university project with a clear clinical focus: finding a better way to support clinicians during complex cardiac care procedures.
Since then, the project has developed into a medtech company with a patented solution, strong clinical collaborations, and a growing network of partners supporting the journey from concept to clinical implementation.
Since then, the project has developed into a medtech company with a patented solution, strong clinical collaborations, and a growing network of partners supporting the journey from concept to clinical implementation.
From Student Project to Startup
EchoVice started in 2021 as a bachelor project created in collaboration with clinical expertise. The early work focused on understanding a real workflow challenge and exploring how engineering could help solve it.
Through Testing and Development
Through prototyping, pre-clinical testing, and continuous redesign, EchoVice has refined its technology with a strong focus on usability, stability, and clinical relevance.
Moving Toward Clinical Impact
Today, EchoVice is preparing for production and market introduction while continuing to develop solutions that can improve workflow, safety, and efficiency in cardiac care.
Project Start
EchoVice began as a bachelor project by Ajith and Jeppe in collaboration with Kristian, with a focus on solving a real clinical workflow challenge in cardiac care.
Q1 2021
Q2 2022
EchoVice ApS Founded
EchoVice ApS was officially established, marking the transition from student project to medtech company.
First MVP Ready for Testing
The first minimum viable product was completed and prepared for early testing, turning the initial concept into a functional prototype.
Q3 2022
Q2 2023
Pre-Clinical Trial Started
EchoVice began pre-clinical testing to evaluate the solution and gather important insights for further development.
Patent Granted
A patent was granted, strengthening the company’s intellectual property position and supporting the future development of the technology.
Q3 2023
Q1 2024
Device Redesign
The device was redesigned to improve usability, function, and readiness for further testing and implementation.
Investment from Christian Nielsen
EchoVice received investment from Christian Nielsen, supporting the company’s continued development and growth.
Q3 2023
Q2 2025
Production Started
EchoVice started production, marking an important step toward clinical implementation and commercial availability.
First Order
EchoVice received its first order, representing a key commercial milestone for the company.
Q3 2025
Q1 2026
White Paper Publication
EchoVice published a white paper documenting key findings, development insights, and the clinical relevance of the solution.
The Team
EchoVice is built by an interdisciplinary team with a shared focus on clinical relevance, practical engineering, and user-centered innovation.
The team combines technical expertise with clinical insight to develop medical device solutions that respond to real needs in cardiac care.
The team combines technical expertise with clinical insight to develop medical device solutions that respond to real needs in cardiac care.
Jeppe Olesen
Co-founder
Jeppe brings engineering expertise and a practical mindset to developing medical device solutions for cardiac care workflows.
Ajithan Christian
Co-founder
Ajithan brings technical knowledge and hands-on product development experience to creating solutions for clinical use.
Kristian Bach Laursen
Clinical collaborator
Kristian brings clinical insight and real-world healthcare knowledge to ensure solutions address actual cardiac care needs.
Supported by
EchoVice is supported by a strong network of investors, grant providers, business partners, and healthcare collaborators. Their support has helped us move from early development and testing toward production, clinical implementation, and continued growth.
Investors
Investors help EchoVice grow from idea to market.
Grants
Grants support our development, testing, and innovation.
Partners
Frequently Asked Questions
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam eget elementum lorem. Proin in lacinia augue. Maecenas congue sem arcu, sit amet euismod ante rhoncus id.
EchoVice develops medical device solutions that support more stable, efficient workflows in cardiac care.
EchoVice is based in Odense, Denmark, with roots in the Danish medtech and life science ecosystem.
Clinicians, hospitals, investors, partners, and organizations interested in cardiac care innovation are welcome to contact us.
Yes. EchoVice works closely with clinical collaborators to develop solutions based on real healthcare needs.
You can reach EchoVice by using the contact form, sending an email to ac@echovice.com, or calling +45 22 39 02 08.
